VALTRICOM 10 mg/160 mg/12,5 mg Румунія - румунська - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

valtricom 10 mg/160 mg/12,5 mg

krka d.d., novo mesto - slovenia - combinatii (amlodipina+valsartan+hct) - compr. film. - 10mg/160mg/12,5mg - antagonisti ai angiotensinaei ii, combinatii antagonisti ai angiotensinaei ii, combinatii

VALTRICOM 10 mg/160 mg/25 mg Румунія - румунська - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

valtricom 10 mg/160 mg/25 mg

krka d.d., novo mesto - slovenia - combinatii (amlodipina+valsartan+hct) - compr. film. - 10mg/160mg/25mg - antagonisti ai angiotensinaei ii, combinatii antagonisti ai angiotensinaei ii, combinatii

VALTRICOM 10 mg/320 mg/25 mg Румунія - румунська - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

valtricom 10 mg/320 mg/25 mg

krka d.d., novo mesto - slovenia - combinatii (amlodipina+valsartan+hct) - compr. film. - 10mg/320mg/25mg - antagonisti ai angiotensinaei ii, combinatii antagonisti ai angiotensinaei ii, combinatii

VALTRICOM 5 mg/160 mg/12,5 mg Румунія - румунська - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

valtricom 5 mg/160 mg/12,5 mg

krka d.d., novo mesto - slovenia - combinatii (amlodipina+valsartan+hct) - compr. film. - 5mg/160mg/12,5mg - antagonisti ai angiotensinaei ii, combinatii antagonisti ai angiotensinaei ii, combinatii

VALTRICOM 5 mg/160 mg/25 mg Румунія - румунська - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

valtricom 5 mg/160 mg/25 mg

krka d.d., novo mesto - slovenia - combinatii (amlodipina+valsartan+hct) - compr. film. - 5mg/160mg/25mg - antagonisti ai angiotensinaei ii, combinatii antagonisti ai angiotensinaei ii, combinatii

Entresto Європейський Союз - румунська - EMA (European Medicines Agency)

entresto

novartis europharm limited - sacubitril, valsartan - insuficienta cardiaca - antagoniști ai angiotensinei ii, alte combinații, agenți care acționează asupra sistemului renină-angiotensină - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.

Neparvis Європейський Союз - румунська - EMA (European Medicines Agency)

neparvis

novartis europharm limited - sacubitril, valsartan - insuficienta cardiaca - agenți care acționează asupra sistemului renină-angiotensină - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.